Water-powered motorcycle: Yamaha's green revolution



by   |  VIEW 223

Water-powered motorcycle: Yamaha's green revolution

How to enter the future of zero-emission car and motorcycle technology? Only water and no fuel: this is Yamaha's response that would have commissioned the French Maxime Lefebvre to study the new XT 500 H2O. It is a bike with a real engine located inside the rear hub, which would take energy from the water, pushed by a pump system through a high pressure injector.

Water that would continually come back to the pump, creating a continuous circulation, for an inexhaustible flow and absolutely zero pollution, even acoustic, despite it could be a hybrid complex, where a battery would electrically power the pump.

In 2015 Lefebvre devised another revolutionary model, a Honda on which the propulsion unit in the shape of a human heart would have the ability to absorb carbon dioxide present in the atmosphere, water and solar energy, transforming them.

in molecular oxygen, therefore in energy. When the new version of the Yamaha XT 500, the legendary bike from 1976 that introduced the on-off style, could have the frame composed of a single central beam, supporting the small saddle, the fork and to which the voluminous water pump.

To which the single-sided rear suspension would be integrated, as it would also include the high-pressure passages for the hub / engine.

The virtual super-hub that studies the DNA of tumors

Cancer Core Europe's Molecular Tumor Board Portal project consists of a virtual super-hub that studies the DNA of tumors.

An article published in the journal Nature Medicine analyzes the results of genomic analyzes of the tumors of patients treated at individual European institutes, in order to put the results of scientific discoveries at the service of the patient.

The seven cancer centers are: the Vall d'Hebron Institute of Oncology (Spain), the Goustave Roussy (France), the Karolinska Institutet (Sweden), the Netherlands Cancer Institute (Holland), the Cancer Research UK Cambridge Center (Great Britain) , the German Cancer Research Center, National Center for Tumor Diseases - DKFZ - (Germany) and the National Cancer Institute of Milan (INT).

Molecular Tumor Board indicates whether genetic counseling is required and provides useful information for including patients in some clinical trials. It also highlights the biomarkers that are important for the diagnosis of the disease, the prognosis and the response to drugs available so far or the possible opportunity to consider experimental and off-label drugs, i.e.

used outside their indication of use. Every week, dozens of cases are discussed in a multidisciplinary context during virtual meetings. The ultimate goal, the researchers explain in the article, is to translate the advances in knowledge resulting from cancer research into clinical practice.

Numerous efforts are currently underway to understand the significance of the genetic-molecular alterations of the tumor and thus improve the capabilities of diagnosis, prognosis and selection of the best therapy